Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Lasergen

company

About

Lasergen is a biotechnology company developing and commercializing technologies for genomic applications.

  • Houston,Texas,United States
  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$80M
Industries
Biotechnology,Genetics,Health Care,Health Diagnostics
Founded date
Jan 1, 2002
Number Of Employee
11 - 50
Operating Status
Active

LaserGen, Inc., a biotechnology company, engages in the development and commercialization of technologies for genomics application. It develops various technologies for sequencing applications. The company's products detect heritable and somatic sequence variations in the human genome for use as diagnostics tools for the management of diseases. LaserGen, Inc. was incorporated in 2002 and is based in Houston, Texas.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$85M
Lasergen has raised a total of $85M in funding over 2 rounds. Their latest funding was raised on Mar 7, 2016 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 7, 2016 Series B $80M 1 Agilent Technologies Detail
Aug 30, 2011 Series A $5M 2 Aspen MedTech Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Lasergen is funded by 3 investors. Agilent Technologies and Aspen MedTech are the most recent investors.
Investor Name Lead Investor Funding Round
Agilent Technologies Yes Series B
Aspen MedTech Yes Series A
LBS Technologies Series A